Overview

A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
1994-02-01
Target enrollment:
Participant gender:
Summary
PhXA41 is not inferior to timolol
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Latanoprost
Timolol